InvestorsHub Logo
Followers 144
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: rosemountbomber post# 115623

Friday, 10/06/2017 9:38:59 AM

Friday, October 06, 2017 9:38:59 AM

Post# of 427770
r-

the inertness of the mineral oil placebo ... If that was a concern

The FDA tried to explain the changes observed in the mineral oil group, since the magnitude of the changes in several lipid and lipoprotein parameters, as well as biomarkers of inflammation, between baseline and Week 12 in the placebo group wre rather atypical for lipid-lowering trials. However they did not conclude anything

These results suggest the changes in ANCHOR are atypical, but the etiology of this remains unclear

and did not suggest any change for R-IT.

Furthermore, R-IT is about clinical outcome (as PE and SEs) lipid values are TEs only (meanwhile ANCHOR was about lipids).

Best,
G

#NEWMIAMI

Disclosure:
I am long with this stock. I wrote this post myself, and it expresses my own opinions (IMHO). I am not receiving compensation for it.

Do Your Job

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News